Adenosine deaminase-deficient mice: Models for the study of lymphocyte development and adenosine signaling

Advances in Experimental Medicine and Biology

Volumn 486, Issue , 2000, Pages 57-63

  Aldrich, M B ^a   Blackburn, M R ^a   Datta, S K ^a   Kellems, R E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE;

ANIMAL MODEL; COMBINED IMMUNODEFICIENCY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME REGULATION; ENZYME REPLACEMENT; GENE MUTATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOSINE; ADENOSINE DEAMINASE; ADENOSYLHOMOCYSTEINASE; ANIMALS; DEOXYADENOSINES; DISEASE MODELS, ANIMAL; HUMANS; HYDROLASES; LYMPHOCYTES; MICE; MICE, KNOCKOUT; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0034470697     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (27)

1. Immunodeficiency disease due to deficiency of adenosine deaminase
2. Biochemical pathways of caspase activation during apoptosis
3. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2′-deoxyadenosine in adenosine deaminase-deficient patients
4. Adenosine deaminase deficiency in two patients with severely impaired cellular immunity
5. ATP channel
6. A1 adenosine receptors modulate respiratory activity of the neonatal mouse via the cAMP-mediated signaling pathway
7. Adenosine Neuromodulation
8. Renal glomerular filtration rate markedly reduces when renal A1 adenosine receptors are activated
9. 2A receptor monoclonal antibodies
10. Adenosine receptor subtypes: Characterization and therapeutic regulation
11. 3 adenosine receptor ligands: History and perspectives
12. A2A adenosine receptors in human peripheral blood cells
13. 3 adenosine receptor in determining tissue levels of cAMP and blood pressure: Studies in knock-out mice
14. 2a receptor
15. Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants
16. The chondroosseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency
17. Hepatic dysfunction as a complication of adenosine deaminase deficiency
18. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency
19. Amelioration of neurological abnormalities after "enzyme replacement" in adenosine deaminase deficiency
20. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency
21. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase
22. Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice
23. Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death
24. Ontogeny of adenosine deaminase in the mouse decidua and placenta: Immunolocalization and embryo transfer studies
25. Adenosine deaminase-deficient mice generated using a two-step genetic engineering strategy exhibit a combined immunodeficiency
26. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction
27. The role of adenosine in asthma